Xi Jinping’s consolidated grip on the Chinese Communist Party, Central Military Commission, and state institutions drives the 95.5% trader consensus against his removal before 2027. Recent personnel appointments, ongoing anti-corruption purges targeting potential rivals, and the absence of any designated successor reinforce expectations that he will pursue a fourth term at the 2027 Party Congress. No public health disclosures, elite defections, or policy reversals have emerged to alter this positioning. Realistic shifts could still arise from an abrupt medical event, severe economic disruption prompting internal pressure, or an unforeseen leadership challenge, though current evidence points to continued dominance through at least the congress.